Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

NCT05373264 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05373264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05373264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Recruiting
Start date
July 31, 2024
Completion date
July 31, 2031
Enrollment
300 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

adpkd